Влияние естественных метаболитов и мышечной деятельности на гликирование белков крыс с индуцированным диабетом
Диссертация
Важнейшим свойством живого организма является обмен веществ. Главной чертой протекающих химических превращений в организмах считается участие в этих реакциях ферментов. Однако в последние годы стало очевидным, что в организме помимо реакций, катализируемых ферментами, протекают и неферментативные процессы. К таким реакциям относится гликирование белков, в ходе которого взаимодействуют свободные… Читать ещё >
Список литературы
- Болдырев А. А. Карнозин. Биологическое значение и возможности применения в медицине // М.: Изд-во МГУ 1998.
- Дупин A.M., Бодырев A.A., Архипенко Ю. В. и др. Защита карнозином транспорта Са2+ от повреждений, вызываемых перекисным окислением липидов //Бюл. Эксп. Биол. Мед. 1984 — т. 97 — с. 186−188.
- Жатон Ж.К., Брандт Д. Ч., Вассали П. Выделение и характеристика антител и их полипептидных цепей // Методы в иммунологии / под. ред. И. Левковитца и В. Перкиса-пер. с анг. М.: Мир -1981 — с. 58−82.
- Карпусь О.В., Рогозкин В. А., Мельгунова Е. А., Фельдкорен Б. И. Влияние систематических физических нагрузок и высокоуглеводного рациона на уровень гликозилированных белков в крови крыс // Физиол. жур. им. И. М. Сеченова 1993 — т.79 — с. 39−43.
- Касаткина Э. П. Роль физических нагрузок в компенсации сахарного диабета // Проблемы эндокринологии 1992 — т. 38 — с. 45−48.
- Касаткина Э.П. Клинико-метаболические нарушения у больных с инсулинзависимым сахарным диабетом //Сахарный диабет у детей и подростков М.: Медицина — 1996 — стр. 46−48.
- Кулева Н.В., Коваленко З. С. Изменение функиональных свойств актина при его гликировании in vitro // Биохимия 1997 — т.62 — вып. 10 — стр. 1307−1313.
- Ленкова Р.И., Усик C.B. Метаболическая адаптация организма к мышечной деятельности возрастющей интенсивности // Физиол. жур. СССР.-1977- с. 858.
- Мальцева В.В., Сергиенко В. И., Стволинский С. Л. Влияние карнозина на активность гематопоэтических стволовых клеток у облученных животных //Биохимия 1995 -т. 57 — с. 1378−1382.
- Матюшечев В.Б. Элементы статистичесой обработки результатов биохимического эксперимента // Учебное пособие Л., 1990.
- Неменова Ю.М., Крюкова Т. М., Любина А. Я., Палее М. Э. Практикум по технике лабораторных работ // М.: Медицина 1968 -с. 210.
- Никитенко Н. Ю. Шавранекий К.Х. Болдырев А. А. Эффект карнозина и его производных на АДФ-зависисмую агрегацию человеческих тимоцитов // Вопр. Мед. Химии 1992 -т.41 — с. 41−43.
- Северин С. Е., Георгиевская Е. Ф. Превращеие карнозина в почках // Биохимия 1938 — т. 3 — с. 148.
- Северин С.Е., Болдырев А. А., Дупин А. М. Биологическая роль гистидиновых дипептидов в возбудимых тканях // Вопр. Мед. Химии -1984-т. 30-е. 32−36.
- Серами Э., Влассара Э., Браунди М. Глюкоза и старение // В мире науки 1987 -№ 7 — с. 42−49.
- Туркова Я. Аффинная хроматография У/ Лабораторное руководство по хроматографическим и смежным методам / под. ред. О. Микоша пер. с анг. — М.: Мир — 1982 — ч.2 -с.405−444.
- Щербанюк А.В., Морозов В. И., Доброгорская М. В. Синтез антигенных производных гликированных белков и получение антител к ним // В кн.: Современные проблемы физической культуры и спорта -Санкт-Петербург -1998-с. 187−190.
- Akinci A., Tezic Т., Erturk G. et. al. Thiamine-responsive megaloblastic anemia with diabetes mellitus and sensorineural deafness //Acta Pediatr. Jpn. -1993 v. 35 -p.262−266.
- Appel G., Bolton K., Freedman B. et. al. Pimagedine lowers total urinary protein and slows progression of overt diabetic nephropathy in patients with type I diabetes // J. Am. Soc. Nephrol. 1999 — v. 10 — p. 153 A.
- Arai K., Iisuka S., Tada Y. et.al. Incraese in the glycasylated form of erytrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glycosylation with the enzyme activity // BBA 1987 — v. 924 -p.292−296.
- Araki N., Ueno N., Chakrabarti B., et. al. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging // J. Biol. Chem. 1992 — v. 267 — p. 10 211−10 214.
- Baldwin S. A. Mammalian passive glucose transorters: members of an ubiquitous familiy of active and passive transport proteins // Biochem. Biophys. Acta-1993-v. 1154-p.17−49.
- Bierhaus A., Hofmann M. A., Zeigler R., Nawroth P.P. AGE and their interaction with AGE-receptors in vascular disease and diabetes. I. The AGE concept // Cardiovacs. Res. -1998 -v.37 -p.586−600.
- Birrell A.M., Heffernan S.J., Ansselin A.D. et. al. Functional and structural abnormalities in the nerves of type I baboons: ammoguanidine does not improve nerve function // Diabetologia 2000 — v.43 — p. 110−116.
- Booth A.A., Khalifah R. G., Hudson B. G. Thiamine phosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine // Biochem. Biophys. Res. Com. -1996-v. 220-p. 113−119.
- Boyd-White J., Williams J.C. Effect of cross-linking on matrix permeability. A model for AGE-modified basement membranes // Diabetes -1996-v.45 -p. 348−353.
- Bradford M. M. A rapid sensitive method for the quantitation of microgram quantities proteins utilizing the principle of protein dye binding // Anal. Biochem. — 1981 — v.72 — p. 247 — 251.
- Brett J., Schmidt A.M., Zou Y.S., et.al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues // Am. J. Phathol. 1993 — v. 143 -p. 1699−1712.
- Brownlee M. Negative consequences of glycation // Metabolism 2000 — v. 49 (Suppl. l)-p. 9−13.
- Brownlee M., Vlassara H., Klooney A. et. al. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking // Science 1986-v.232 -p.1629−1632.
- Brownlee M., Vlassara H., Kooney A., et. al. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking // Science 1986 -v. 232 -1629−1632.
- Brownson C., Hipkiss A. R. Carnosine reacs with a glycated protein // Free Radic. Med. 2000 — v.28 — p. 1564−1570.
- Bucala R. Lipid and lipoprotein modification by AGE’s: role atherosclerosis // Exp.Physiol. 1997 -v.82 -p.327−337.
- Bucala R., Makita T., Koschinsky T., et. al. Lipid advanced glycosylation: pathway for lipid oxidation in vivo // Proc. Natl. Acad. Sci. 1993- v. 90 -6434−6438.
- Bucala R., Eracey J., Cerami A. Advaced glycosltion products quench nitric oxide and mediate defective endothelium -dependent vasodilatation in experimental diabetes//J.Clin. Invest. 1991 — v.87-p.432−438.
- McCance D.R., Dyer D.G., Dunn J. A., et. al. Maillard reaction products and their relation to complications in insulin dependent diabetes mellitus // J. Clin. Invest.-1993-v.91 -p.2470−2478.
- Ceriello A. Hyperglycemia: the bridge between non-enzymatic glycation and oxidative stress in the pathology of diabetic complication // Diabetes Nutr. Metab. -1999- v. 12- p42−46.
- Chellan P., Naragaj R.H. Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes // Arch. Biochem. Boiphys. 1999 -v. 368 — p. 98−104.
- Chueyn N.V. Maillard reaction and food processing. Application aspects //Adv. Exp. Med. Biol. 1998 — v. 434 -p. 213−215.
- Cockroft K.M., Meistrell M., Zimmerman G. A. et. al. Cerebroprotective effects of aminoguanidine in rodent model of stroke // Stroke 1996 -v.27 -p.1393−1398
- Colaco C.A., Ladesma M.D., Harrington C.R., Avila J. The role of the Maillard reaction in other pathology: Alzheimer’s disease // Nephrol. Dial. Transplant. 1996 — v. 11 (Suppl. 5) — p. 7−12.
- Cortright R. N., Dohm G. L. Mechanisms by which insulin and muscle contraction stimulatr glucose transport // Can. J. Appl. Physiol. 1997 — v.22 -p. 519−30.
- Day J.F., Ingelbretsen C.G., Ingelbretsen W.R. et. al. Nonenzymatic glycosilation of serum proteins and hemoglobine: response to change in blood glucose levels in diabetic rats // Diabetes 1980 — v. 29 — p. 524- 527.
- Di G.X., Fu P.Y., Tend W.P. et. al. Exercise therapy of non-insulin dependent diabetes mellitus. Effect of acute loading // Clin. Med. J. 1993 -v. 106-p. 406−409.
- Earnests C.P., Snell P.G., Rodriguez R., et. al. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strehgth and body composition // Acta Physiol. Scand. 1995 — v. 153 — p. 207−209.
- Edward M. R., Hopkins W. G. Blood glucose following training sessions in runners // Int. J. Sports Med. 1993 — v. 14 — p. 9−12.
- Franke S., Niwa T., Deuther-Conrad W., et.al. Immunochemical detection of imidazolone in uremia and rheumatoid arthritis // Clin. Chim. Acta 2000 — v. 300-p. 29−41.
- Frye E.B., Degenhardt T.P., Thorpe S.R., et.al. Role of Maillard reaction in aging of tissue proteins // J.Biol. Chem. 1998 -v. 273 -p.-18 714−18 719.
- Fyjita T., Suzuki K., Tada T., Yoshihara Y. et. al. Human erytrocyte bis-phosphoglycerate mutase: inactivation by glycation in vivo and in vitro // J. Biochem. 1998 -v. 124 -p. 1237−1244.
- Ganea E., Rixon K.C., Harding J.J. Binding of glucose, galactose and pyridoxal phosphate to lens cryctallins // Biochim. Biophys. Acta 1994 — v. 1226-p. 286−290.
- Gelisgen R., Seven A., Ozturk M. et. al. Sorbitol content and ultrastructure of the aortic tissues of streptozotocin diabetic rats: relation to plasma glucose, glycated hemoglibine and blood sorbitol // Biochem. Soc. Trans. 1993 — v. 21 -p. 2865.
- Giardino I., Edelstein D., Brownlee M. Nonenzymatic glycosylation in vitro and bovine endothelial cells alters basic growth factor activity: a model for glycosylation in diabetes // J. Clin. Invest. 1994 — v. 94 — p. 110−117.
- Glomb M., Monnier V.M. Mechanism of protein modification by glyoxal and glyoxalaldehyde, reactive intermediates of the Maillard reaction // J. Biol. Chem. 1995 — v.270 — p. 10 017−10 026.
- Goodyear L.J., Kahn B.B. Exercise, glucose transport, and insulin sensitivity // Annu. Rev. Med. 1998 -v. 49 — p. 235−261.
- Gugliucci A., Allard M.-F. Glycation of hepatocyte cytosolic proteins in streptozotocin-induced diabetic rats // Biochem. Biophys. Res. Com. 1996 -v. 229 -p. 952 -95.
- Hobara R., Kato H., Sakamoto K. Effect of thiamine thiamine levels on experimental alloxan induced diabetes mellitus // Jpn. J. Pharmacol. 1983-v. 33-p. 27−33.
- Hon K., Miyata T., Maeda K. et. al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions // J. Clin. Invest. 1997- v. 100 — p.2995−3004.
- Horiuchi S., Higashi T., Ikeda K., et.al. Advanced glycation end products and their recognition by macrophage and macrophage-derived cells // Diabetes1996- v. 45 (Suppl.3) -p. S73−76.
- Hipkiss A. R., Michaelis J., Syrris P. Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-=cross-linking agent // FEBS Letters 1995 -v.371 -p.81−85.
- Hirata C., Natano H., Nakamura N., et. al. Advanced glycation end products induce expression of vascular growth factor by retinal Muller cells // BBRC1997-v.236-p.712−715.
- Horiuchi S., Araki N., Morino Y. Immunochemical approach to characterized advanced glycation end products of the Maillard reaction // J. Biol. Chem. 1991 — v. 266 — p. 7329−7332.
- Horton E.S. Exercise and diabetes mellitus // Med. Clin. North. Am. 1988 4-V.72- p. 1301−1321.
- Hunt J.V., McKay A.C., Skamarauskas J.I. The pro-oxidant activity of aminoguanidine and protein glycation // Biochem. Soc. Trans. 1995 — v. 23 -250S
- Ienaga K., Nakamura K., Hochi T., et.al. Crosslines. Fluorophores in the AGE-related cross-linked proteins // Contrib. Nephrol. 1995 v. 112 -p.42−51.
- Ikeda k., Higashi T., Sano H. et. al. N?-(carboxymethyl)lysme protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction // Biochemistry 1996 -v.35 — p. 80 758 083.
- Ino-ue M. Effect of aminoguanidineon optic nerve involvement in experimental diabetic rats // Brain Res. -1998 -v. 80 (2) -p. 319−322.
- Jackson M. C., Kucera C.M., Lenney J.F. Purification and properties of human serum carnosinase // Clin. Chim. Acta 1991 — v. 196 — p. 193−206.
- Jain S.K., Lim G. Pyridoxine and pyridoxamine inhibits superoxide radical and prevent lipid peroxidation, protein glycosylation, and (Na+ +K+)-ATPase activity in high glucose-treated human erythrocytes // Free Radic. Biol. Med. -2001 -v. 30-p. 232−237.
- Jennings P.E., Chirico S., Jones A. F. et. al. Vitamin C and microangiopathy in diabetes mellitus // Diabetes Res 1987 — v.6 — p. 151−154.
- Jlao Y., Okumiya T., Salbara T. Abnormality deacreased HbAlc can be assessed with erythrocyte creatine in patients with a shortened erythrocyte age // Diabetes Care 1998 — v. 21 -p. 1732 — 1735.
- Khalifah R. G., Baynes J.W., Hudson B.G. Amadorine: novel post-amadori inhibitors of advanced glycation reaction // Biochem. Biophys. Res. Com. -1999-v. 257-p. 251−258.
- Khatami M., Suldan Z., David A., et. al. Inhibitory effect of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation // Sibe Science 1888-v. 43 — p. 1725−1731.
- Kirstein ML, Aston C., Hintz R., Vlassara H. Receptor-specific induction of insulin-like growth factor (IGF-1) in human monocytes by advanced glycosylation endproducts-modified proteins // J. Clin. Invest. 1992 — v. 90 -p. 439−446.
- Kunt T., Forst T., Wilhelm A., e.a. Alpha-lipoic acid reduced expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end-product // Clin. Sci. -1999-v. 96-p. 75−82.
- Kurata T., Fujmaki M. Role of xylosone in the browning reaction of dehydro-S-ascorbic acid II Agric.Biol. Chem. -1976 v.40 — p. 1429−1430.
- Kuzuya M.- Asai T., Kanda S., et. al. Glycation cross-link inhibit matrix metalloporteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice // Diabetologia 2001-v.44- p.433−436.
- Laemmli U.K. Cleavage of structural proteins during the assembly of the head bacteriofag T4 // Nature 1970 — v. 227 -p. 881.
- Lander H.M., Tauras J.M., Ogiste J.S., et.al. Activation for receptor for AGE triggers a p21 ras dependent mitogen activated protein kinase pathway regulated by oxidant stress //J. Biol. Chem. 1997 -v. 272 — p. 17 810−17 814.
- Lavoie C., Ducros F., Bourque J., et. al. Glucose metabolism during exercise in man: the role of insuline and glucagons in the regulation of hepatic glucose production and gluconeogenesis // Can. J. Physiol. Pharmacol. 1997 -v. 75 -p.26−35.
- Lee H. B., Cha M.K., Song K.I. et. al. Pathogenic role of AGE’s in diabetic nephropathy // Kidney Int. 1997 — v. 52 (suppl.66) — p. S60-S65.
- Lenney J.F., George R.F., Weiss A.M. et. al. Human serum carnosinase and activation by cadmium // Clin. Chim. Acta 1982 — v. 123 — p. 221−231.
- Li J., Schmidt A. M. Characterization and functional analysis of the promoter of RAGE // J. Biol. Chem. -1997- v. 272 p. 16 498−16 506.
- Li J.J., Dickson D., Hof P.R., Vlassara H. Receptor for advanced glycosylation endproducts in brain: role in brain homeostasis II Mol. Med. -1998-v. 4(1)-p. 46−60.
- Li Y. M, Mitsuhashi T., Wojciehowicz D., et.al. Molecular identity and tissue distribution of advanced glycation endproduts receptors. Relationship of p60 to OST 48 and 80KH membrane protein // Proc. Natl.Acad. Sci. USA -1996-v. 93-p. 11 047−11 052.
- Lipovac V., Gavellla M., Vucic M. et. al. Effect of creatine on erythrocyte rheology in virto // Clin. Hemorheol. Microcirc. 2000 — v. 22 — p. 45−52.
- Litchfield J. E., Thorpe S. R., Baynes J. W. Oxygen is not required for the browing and crosslinking of protein by pentoses: relevance to Maillard reaction in vivo // Int. J. Biochem. Cell. Biol. 1999 — v. 31 — p. 1297−1305.
- Luo L., Hensch T.K., Ackerman L., et.al. Diffferent effects of the Rac GTPase on Purkinje cell axons and dendric trunks and spines // Nature -1996-v. 379 p.837−840.
- Maillard L.C. Action des acides amines sur les sucre: formation des melanoidines par voie methodoque // C.R. Acad. Sci. -1912-v. 154 -p. 66−68.
- Makita Z., Radoff S., Rayfield E.J. et. al. Advanced glycation end prodiucts in diabetic nephropathy // New Eng. J. Med. -1991- v. 325 p. 836−842.
- Miyata T., Sugiyama S., Suzuki D., e.a. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy // Kidney Int. 1999 — v. 56 (Suppl.7), P-S54-S56.
- Makita Z., Vlassara H., Cerami A., Bucala R. Immunochemical detection of advanced glycosylation end products in vivo // J. Biol. Chem. 1992 — v. 267 -p. 5133−5138.
- Menzel E.J., Reihsner R. Comparison of the effect of different inhibitors of the nonenzymatic glycation of the rat tail tendon and bovine serum albumin // Ann. Clin. Biochem. 1996 -v-33(Pt.3) -p.241−248.
- Miyata T., Ueda Y., Horie K. et. al. Renal catabolism of advanced glycation end products: the fate of pentosidine // Kidney Int. 1998 — v. 53 — p. 416−422.
- Molina P.E., Yousef K.A., Smith R. M. et. al. Thiamine deficiency impairs endotoxine-induced increase in hepatic glucose output // Am. J. Clin. Nutr. -1994-v. 59-p. 1045−1049.
- Monneir V. M., Sell D.R., Nagaraj R.H. et.al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia // Diabetes 1992 — v.41 (suppl.2) — p. 36−41.
- Monneir V. M., Nagaraj R. H, Portero-Otin M., et.al. Structure of advanced Maillard reaction products and their phatological role // Nephrol. Dial. Transplant.-1996-v. 11 (suppl.5) p.20−26.
- Morimitsu Y., Yoshida K., Esaki S., Hirota A. Protein glycation inhibitors from Thyme (Thimus vulgaris) // Biosci. Biothec. Biochem. 1995 — v. 11 — p. 2018−2021.
- Myint T., Hoshi S., Ookawara T. et. al. Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG // Biochim. Biophys. Acta 1995 — v. 1272 — p.73−79.
- Nagaraj R. H., Monnier Y. M. Protein modification by the degradation products of ascorbate: formation of a novel pyrrol from the Maiiard reaction of L-threose with proteins //Biochim. Biophys. Acta 1995- v. 1253(1) — p.75−84.
- Nakamura Y., Horii Y., Nishino T., et. al. Immunohistichemical localization of advanced glycosylation endproducts (AGEs) in coronaty atheroma and cardiac tissue in diabetes // Am. J. Pathol. 1993- v. 143 — p. 1649−656.
- Neeper M., Schmidt A. M., Brett J. et. al. Cloning and expression of RAGE: a cell surface receptor for advanced glycation end products of proteins // J. Biol. Chem. 1992- v.267- p. 14 998−15 004.
- Nicholl I.D., Bucala R. Advanced glycation endproducts and cigarette smoking // Cell Mol. Biol. 1998 — v. 44 — p. 1025−1033.
- Nilson B. O. Biological effects of aminoguanidine: an update II Inflammation Research 1999-v. 48-p. 509−515.
- Niwa T. 3-Deoxyglucosone: metabolism, biological activity, and clinical implication // J. Chromatogr. B. Boimed. Sci. Appl. 1999 — v. 731 — p. 23−36.
- Obayashi H., Nakano K., ShigetaH., Yamaguchi M. Formation of crossline as fluorescent advanced glycation end product in vitro and in vivo II Biochem. Biophys. Res. Commun. 1996 — v.226-p. 37−41.
- Oimomi M., Igaki N., Effect of aminoguanidine on the glycation // Kobe. J. Med. Sci. 1989 — v.35- p.255−259.
- Okada M., Ayabe Y. Effect of aminoguanidine and pyridoxal phosphate on glycation reaction of aspartate aminotransferase and serum albumine // J. Nutr. Sci. Vitaminol. 1995 — v.41 -p.43−50.
- Okada M., Ayabe Y. Glycation and inactivation of aspartate aminotransferase in diabetic rat tissues II J. Nutr. Sci. Vitaminol. -1997 -v. 43 -p.463−469.
- Omar Farouque H.M., O’Brien R.C., Meredith I.T. Diabetes and coronary heart disease from prevention to intervention: Part 1II Aust.N.Z. J. Med. -2000 -v.30 -p.351−359.
- Ookawara T., Kawamura N., Kitagawa Y., Taniguchi N. Site-specific and random fragmentation of Cu-Zn-superoxide dismutase by clycation reaction // J. Biol. Chem. 1992 — v. 267 — p. 18 505−18 510.
- Ou P., Wolff S.P. Amonoguanidine increases hydrogen peroxide formation during glycation in vitro // Spec. Publ. R. Soc. Chem. -1994 — v. 151 — 329 334.
- Ochterlony O. Immunodiffusion and experimental immunology // Blackwell Sci. Publ., Oxford-Edinburg, Ed. Weir D.R. 1967 -p.655−706.
- Pederson O., Beck -Nielsen H., Heding L. Increased insulin receptors after exercise in patients with insulin-depending diabetes //New Engl. J. Med. 1980 -v. 320-p. 886−892.
- Pitchetsrieder M., Seidel W" Munch G., Schinzel R. N (2)-(l-carboxyethyl)deoxyguanosine, a nonenzymatic glycation adduct of DNA, induces single-strand breaks and increases mutation frequencies // Biochem. Biophys. Res. Com. 1999 — v.264 -p.544−549.
- Raskin P. Caltran D., William M. et. al. Pimagedine reduces progression of retinopathy and lowers lipid concentrations in patients with type I diabetes // J. Am. Soc. Nephrol. 1999 — v. 10 — p. 179 A.
- Rathanaswami P., Sundaresan R. Effect of thiamine on the biosynthesis of insulin in rats // Biochem. Int. 1991 — v.24 -p. 1057−1062.
- Rathanaswami P., Pourany A., Sundaresan R. Effect of thiamine deficiency on the secretion of insulin and the metabolism of glucose in isolated rat pancreatic islets // Biochem. Int. 1991- v. 25 — p. 577 — 583.
- Reddy S., Bichler J., Well-Knecht K. et. al. Ns-(carboxymethyl)lysine is the dominant advanced glycation end product (AGE) antigen in tissue proteins // Biochemistry 1995 — v. 34 — p. 10 872 — 10 878.
- Requena J.R., Ahmed M.U., Fountain C.W., et. al. Carboxymethylethanolamine, a biomarker of phospholipid modification during the Maillard reactio in vivo//J. Biol. Chem- 1997-v. 272-p. 17 473−17 479.
- Richter E. A., Turcotte L., Hespel P., Kiens B. Metabolic responses to exercise: effect of endurance training and implication for diabetes. Diabetes Care 1992 v.15 (Suppl. 4)-p.l767−1776.
- Ritthaler U., Deng Y., Zhang Y., et. al. Expression of receptors for AGE 's in peripheral occlusive vascular disease // Am. J. Pathol. -1995 -v. 146-p.688−694
- Rocic B., Turk Z., Misur I., Vucic M. Effect of creatine on glycation of albumine in vitro // Horm. Metab. Res. 1995 — v. 27 — p. 511 — 512.
- Rogozkin v., Osipova E., Feldkoren B. Blood glycated proteins as an index of carbohydrates metaboism in athletes // Second IOG World Congress on Sport' Sciences, Barcelone 1991 — p. 238.
- Sano H., Higashi T., Matsumoto K., et. al. Insulin enhance macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products // J. Biol. Chem. 1998- v.273- p.8630−8637.
- Shaw S. M., Crabbe J. C. Monitoring the progress of non-enzymatic glycation in vitro // Int. J. Peptide Protein Res 1994 — v. 44 — p. 594 — 602.
- Schmidt A.M., Hori O., Brett J. et.al. Cellular receptors for AGEs // Arterioscler. Thomb. 1994 -v. 14- p. 1521−1528.
- Schedel J. M., Tanaka H., Kiyonaga A. et. al. Acute creatine ingestion in human: consequences on serum creatine and creatinine concentrations // Life Sci. 1999 — v. 65 — p. 2463 — 2470.
- Schmid C., Vormbrock R., Determination of glycosylated hemoglobin by affinity chromatography // Anal. Chem. 1984 — v. 317 -p. 703−704.
- Sell D.R. Monnier V. M. End-stage renal disease and diabetes catalyze the formation of a pentose derived crosslink from aging human collagen // J. Clin. Invest. -1990- v. 85 -p. 380−384.
- Seidel W., Pitchetsrieder M. DNA-glycation leads to depurination by loss of N2-carboxyethylguanine in vitro // Cell. Mol. Biol. 1998 -v.44 -p. 11 651 170.
- Shilton B. H., Walton D.J. Site of glycation of human and horse liver alcohol dehydrogenas in vivo // J. Biol. Chem. 1991 — v. 266 — p. 5587−5592.
- Siguiama S., Miyata T., Hori K., e.a. Advanced glycation end products in diabetic nephropathy I I Nephrol. Dial. Transplant. 1996 — v. 11 (Suppl.5) — p. 91−94.
- Sima A. A., Sugimoto K. Experimental diabetic neuropathy: an update // Diabetologia 1999 v.42-p. 773−788.
- Sinclair A.J., Girling A. J., Gray L. et. al. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation // Diabetologia 1991 -v.34 — p. 171−175.
- Smerdsrod B., Melkko J., Araki N., et.al. AGE’s are eliminated by scavenger receptor mediated endocytosis of hepatic sinusoidal kupffer cells and endothelial cells //Biochem. J. -1997 -v. 322 p. 567−573.
- Som S., Basu S., Mukherjee D. e.a. Ascorbic acid metabolism in diabetes mellitus //Metabolism 1981 -v.30 -p.572−577.
- Soulis T., Sastra S., Thalas V. et. al. A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes // Diabetilogia 1999- v. 42 — p. 472−479.
- Soulis-Laparota T., Cooper M., Papazoglou D. et. al. Retardation by aminoguanidine of development of albuminuria, mesanglial expansion and tissue fluorescence in srteptozotocine-induced diabetic rat // Diabetes 1991 -v. 40-p. 1328−1334.
- Soulis T., Thallas V., Yousset S., et. al. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury // Diabetilogia 1997 — v. 40 — p. 619 — 628.
- Stacpoool P.W., Harwood H.J., Cameron D.F., et. al. Chronic toxity of dichloroacetate relation to thiamine deficiency in rats // Fundam. Appl. Toxicol. 1990 — v. 14-p. 327−337.
- Stitt A.W., Freidman S., et. al. Elevated AGE-modified Apo B in sera of euglycemic, Normolipidaemic patiens with atherosclerosis: relation to tissue AGE // Mol. Med. 1997 — v. 3 — p.617−627.
- Stitt A.W., Bucala R., Vlassara H. Atherogenesis and advanced glycation promotion? Progression and prevention // Ann. N.Y. Acad. Sci. 1997 — v. 811 -p. 100−115.
- Sung-Hee Ihm, Hyung Joon Yoo, Sung Woo Park, Jahei Ihm. Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats // Metabolism 1999-v.48-p. 1141−1145.
- Swamy-Mrithinti S., Carter A.L. Acetyl-L-carnitine decreases glycation of lens proteins: in vito studies // Exp. Eye Res. 1999 — v. 69 -p. 109−115.
- Swamy-Mruthiti S., Shaw S.M., Zhao H.R. et. al. Evidence of a glycemic threshold for the development of cataracts in diabetic rats // Curr. Eye Res. -1999-v. 18-p. 423−429.
- Swearengin T.A., Fitzgerald C., Seilder N. W. Carnosine prevents glyceraldehydes 3-phosphate-mediated inhibition of aspartate aminotransferase //Arch. Toxicol. 1999 — v. 73- p.307−309.
- Taguchi T., Sugiura M., Hamada Y., Miwa I. Inhibition of advanced protein glycation by a Shiff base between aminiguanidine and peridoxal //Eur. J. Pharmacol. 1999 — v.378 — 283−289.
- Taguchi T., Sugiura M., Hamada Y., Miwa I. In vivo formation of a Schiff base of aminoguanidine with pyridoxal phosphate // Biochem Pharmacol -1998- v. 55 p.- 1667−1671.
- Tessier F., Moreaux V., Birlouerz-Aragon I. e.a. Decrease in vitamin C concentration in human lenses during cataract progression // Int. J. Vitam. Nutr. Res.-1998-v.68-p. 309−315.
- Thornalley P.J., Langborg A., Minhas H.S. Formation of glyoxal, methylglyoxal and 3-DG in the glycation of proteins // Biochem. J. 1999- v. 344-p. 109−116.
- Thorpe S.R., Baynes J.W. Role of the Maillard reaction in diabetes mellitus and disease of aging // Drugs Aging -1996 v. 9- p.69−77.
- Valerio G., Frazese A., Poggi V. et. al. Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus // Acta Diabetol. 1999 — v. 36-p. 73−76.
- Vlassara H., Brownlee M., Cerami A. Non-enzymatic glycosylation of peripheral nerve protein in diabetes // Proc. Natl. Acad. Sci. USA -1981 -v. 78 -p. 5190−5192.
- Vlassara H., Brownlee M., Cerami A. High-affinity receptor mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules // Proc. Natl. Acad. Sci. USA 1985 -v. 82-p.5588−5592.
- Vlassara H., Brownlee M., Cerami A. Novel macrophage receptor for glucose-modified protein is distinct from previously described scavenger receptors // J. Exp. Med. 1986 — v. 164 -p. 1301−1309.
- Vlassara H., Li M. Y., Imani F. et. al. Identification of Galectin-3 as a binding protein for advanced glycation endproducts (AGE): a new member of AGE-receptor complex // Mol. Medicine 1995 — v. 1- p.634−646.
- Verbeke P., Perichon M., Friguet B., Bacala H. Inhibition of nitric oxide synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells // Biochem. Biophys. Acta 2000 -v. 1502-p. 481−494.
- Verzijl N., Degroot j., Oldehinkel E., et. al. Age-related accumulation of Maillard reaction products in human artucular cartilage collagen // Biochem. J.-2000-v. 350 (Pt2)-p. 381−387.
- Vinson J. A., Howard III T. B. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients // J. Nutr. Biochem. 1996 -v. 7 — p.659−663.
- Wahren J. Metabolic adaptation to physical exercise in diabetes mellitus // J. Jap. Diab. Soc. 1980 -v 23 -p. 997−1001.
- Weiss M.F., Erhard P., Kader-attia F.A., et.al. Mechanisms for the formation of glycoxidation products in end-stage renal disease // Kidney Int.-2000-v. 57-p.2571−85.
- Well-Knecht K.J., Brinkmann E., Well-Knecht M. C., et.al. New biomarkers of Maillard reaction damage to proteins // Nephrol. Dial. Transplant.-1996-v. 11 (suppl.5) p.41−47.
- Weykamp C. W., Penders T. J., Baadenhuijsen H., et. al. Vitamin C and glycohemoglobine // Clin. Chem. 1995 — v.41 — p. 713−716.
- Whittier F., Spinowitz B., Wuerth J.P. Pimagedine safety profile in patients with type I diabetes // J. Am. Soc. Nephrol. V. 10 p. 184 A.
- Wolffenbuttel B. H., Boulanger Ch. M., Crijns F. Breakers of advanced glycation end product restore large artery properties in experimental diabetes // Proc. Natl. Acad. Sci. 1998 — v.14 — p. 4630−4634.
- Wolffenbuttel B.H.R., Giordano D., Founds H. W., Bucala R. Long-term assessment of glucose control by haemoglobin-AGE measurement //Lancet1996-v. 347-p. 513−515.
- Yan S.D., Fu J., Soto C. et.al. An intracellular protein that binds amyliod-beta pepetide and mediates neurotoxicity in Alzheimer’s disease // Nature1997-v. 382 -p.685−691.
- Yan S.D., Schmidt A.M., Anderson G.M., et. al. Enhanced cellular oxidant stress by the interaction of AGE’s with their receptor/binding proteins // J. Biol. Chem. 1994-v. 269-p.9889−9897.
- Yung Z., Makita Z., Horii Y., et. al. Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins // J. Exp. Med. 1991- v. 174- p. 515 524.
- Zhao W., Devamanoharan P. S., Varma S. D. Fructose mediated damage to lens alpha-crystallin: prevention by pyruvate // Biochem. Biophys. Acta 2000-v.1500 -p.161−16
- Zimmerman G A., Meistrell III M., Bloom O., et. al. Neurotoxity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine //Proc. Natl. Acad. Sci. USA 1995- v. 92 — p. 3744−3748.